The present invention relates to oral pharmaceutical compositions in the form of orally dispersible tablets containing calcium and optionally vitamin D and/or fluorine combined with pharmaceutically acceptable excipients useful for treatment or prevention of osteoporosis and other diseases characterized by loss of bone mass.